These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34714068)

  • 21. Advances in nucleic acid amplification techniques (NAATs): COVID-19 point-of-care diagnostics as an example.
    Kang T; Lu J; Yu T; Long Y; Liu G
    Biosens Bioelectron; 2022 Jun; 206():114109. PubMed ID: 35245867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Cas Systems: Programmable Nuclease Revolutionizing the Molecular Diagnosis.
    Pandya K; Jagani D; Singh N
    Mol Biotechnol; 2024 Aug; 66(8):1739-1753. PubMed ID: 37466850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrying out pseudo dual nucleic acid detection from sample to visual result in a polypropylene bag with CRISPR/Cas12a.
    Wu H; Chen Y; Shi Y; Wang L; Zhang M; Wu J; Chen H
    Biosens Bioelectron; 2021 Apr; 178():113001. PubMed ID: 33493900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variants.
    Li J; Zhang K; Lin G; Li J
    J Med Virol; 2024 Jan; 96(1):e29356. PubMed ID: 38180237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.
    Weng Z; You Z; Yang J; Mohammad N; Lin M; Wei Q; Gao X; Zhang Y
    Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202214987. PubMed ID: 36710268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances and clinical application in point-of-care testing of SARS-CoV-2.
    Ye Q; Lu D; Zhang T; Mao J; Shang S
    J Med Virol; 2022 May; 94(5):1866-1875. PubMed ID: 35080017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR Approaches for the Diagnosis of Human Diseases.
    Puig-Serra P; Casado-Rosas MC; Martinez-Lage M; Olalla-Sastre B; Alonso-Yanez A; Torres-Ruiz R; Rodriguez-Perales S
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four thermostatic steps: A novel CRISPR-Cas12-based system for the rapid at-home detection of respiratory pathogens.
    Fang J; Liu J; Cheng N; Kang X; Huang Z; Wang G; Xiong X; Lu T; Gong Z; Huang Z; Che J; Xiang T
    Appl Microbiol Biotechnol; 2023 Jun; 107(12):3983-3996. PubMed ID: 37166482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Based COVID-19 Smartphone Test in Development.
    Abbasi J
    JAMA; 2021 Feb; 325(6):522. PubMed ID: 33560305
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review.
    Habimana JD; Huang R; Muhoza B; Kalisa YN; Han X; Deng W; Li Z
    Biosens Bioelectron; 2022 May; 203():114033. PubMed ID: 35131696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Portable RT-LAMP/CRISPR Machine for Rapid COVID-19 Screening.
    Rezaei M; Razavi Bazaz S; Morshedi Rad D; Shimoni O; Jin D; Rawlinson W; Ebrahimi Warkiani M
    Biosensors (Basel); 2021 Oct; 11(10):. PubMed ID: 34677325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A warm-start digital CRISPR/Cas-based method for the quantitative detection of nucleic acids.
    Wu X; Chan C; Springs SL; Lee YH; Lu TK; Yu H
    Anal Chim Acta; 2022 Mar; 1196():339494. PubMed ID: 35151407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics.
    Kumar P; Malik YS; Ganesh B; Rahangdale S; Saurabh S; Natesan S; Srivastava A; Sharun K; Yatoo MI; Tiwari R; Singh RK; Dhama K
    Front Cell Infect Microbiol; 2020; 10():576875. PubMed ID: 33251158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing CRISPR-Cas-Mediated Detection of Nucleic Acid and Non-nucleic Acid Targets Using Enzyme-Labeled Reporters.
    Samanta D; Ebrahimi SB; Ramani N; Mirkin CA
    J Am Chem Soc; 2022 Sep; 144(36):16310-16315. PubMed ID: 36040193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress and bioapplication of CRISPR-based one-step, quantitative and multiplexed infectious disease diagnostics.
    Shen Y; Hu K; Yuan M; Duan G; Guo Y; Chen S
    J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36813257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research progress of visual detection in rapid on-site detection of pathogen nucleic acid.
    Liu DN; Wu HP; Zhou GH
    Yi Chuan; 2023 Apr; 45(4):306-323. PubMed ID: 37077165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-cas technology: A key approach for SARS-CoV-2 detection.
    Fang L; Yang L; Han M; Xu H; Ding W; Dong X
    Front Bioeng Biotechnol; 2023; 11():1158672. PubMed ID: 37214290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ultrasensitive and specific point-of-care CRISPR/Cas12 based lateral flow biosensor for the rapid detection of nucleic acids.
    Mukama O; Wu J; Li Z; Liang Q; Yi Z; Lu X; Liu Y; Liu Y; Hussain M; Makafe GG; Liu J; Xu N; Zeng L
    Biosens Bioelectron; 2020 Jul; 159():112143. PubMed ID: 32364943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A CRISPR-Cas12a-derived biosensor enabling portable personal glucose meter readout for quantitative detection of SARS-CoV-2.
    Huang D; Shi Z; Qian J; Bi K; Fang M; Xu Z
    Biotechnol Bioeng; 2021 Apr; 118(4):1587-1596. PubMed ID: 33410130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.